Fresenius | FRE - Operating Profit


Fresenius reported EUR719M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Akzo Nobel EUR -73M 324M Sep/2026
Alcon AG USD 44M 253M Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
BASF EUR -131M 1.57B Sep/2026
Bayer EUR 827M 2.7B Jun/2026
Beiersdorf EUR 760M 256M Jun/2026
DaVita Healthcare Partners USD 570.82M 97.27M Jun/2026
Demant DKK 2.12B 35M Jun/2026
E.ON EUR 1.14B 2.97B Jun/2026
Essilor EUR 2.3B 919M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 537.27M 269.27M Jun/2026
Getinge SEK 1.35B 268M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GN Store Nord DKK 58M 126M Jun/2026
GRIFOLS EUR 329M 80M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.1B 51M Jun/2026
Novartis USD 4.75B 515M Jun/2026
Philips EUR 610M 308M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
RWE EUR 1.38B 1.52B Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
Smith & Nephew USD 505M 65M Jun/2026